Daniel Welch
Chairman bei NUVATION BIO INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Lars Ekman | M | 74 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 23 Jahre |
| David Hung | M | 66 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 6 Jahre |
| Gene Kinney | M | 55 | 12 Jahre | |
| Jerome B. Durso | M | 56 |
Sanofi-Synthelabo, Inc.
| 30 Jahre |
| Ted Love | M | 65 | 4 Jahre | |
| Oleg Nodelman | M | 47 | 5 Jahre | |
| Eric Dobmeier | M | 55 | 19 Jahre | |
| Carlos A. Schuler | M | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 15 Jahre |
| Raymond Stevens | M | 60 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 Jahre |
| Jun Yoon | M | 46 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 Jahre |
| Shane Cooke | M | 61 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 23 Jahre |
| Emil Kakkis | M | 63 | 14 Jahre | |
| Thomas Kassberg | M | 63 | 18 Jahre | |
| Robert B. Bazemore | M | 56 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 4 Jahre |
| Rocco Venezia | M | 48 | 8 Jahre | |
| Ramy Farid | M | 59 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 Jahre |
| Tran Nguyen | M | 50 | 11 Jahre | |
| Moses Makunje | M | 46 | 4 Jahre | |
| Kim Blickenstaff | M | 71 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 5 Jahre |
| Tony Vernon | M | 68 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 5 Jahre |
| Sharon Tetlow | F | 64 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 2 Jahre |
| Kathryn Falberg | F | 63 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 4 Jahre |
| Randy Fawcett | M | - | - | |
| Wagner M. Zago | M | 51 | 12 Jahre | |
| Shehnaaz Suliman | M | 52 | 5 Jahre | |
| Michelle Doig | F | 50 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | 3 Jahre |
| Paula Cobb | F | 51 | 5 Jahre | |
| Jared M. Freedberg | M | 55 | 3 Jahre | |
| Michael J. Malecek | M | 58 | 5 Jahre | |
| Eric Crombez | M | - | 7 Jahre | |
| Douglas Maffei | M | - | 4 Jahre | |
| Deborah Dunsire | M | 61 | 7 Jahre | |
| Amrit Ray | M | 51 | 2 Jahre | |
| Alan Colowick | M | 61 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 7 Jahre |
| Joanne Waldstreicher | M | 63 | 2 Jahre | |
| James Brody | M | - |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 8 Jahre |
| Xi Chen Lin | M | 50 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 Jahre |
| Karl Härfstrand | M | 66 | 9 Jahre | |
| Richard Collier | M | 70 | 12 Jahre | |
| Brandon Smith | M | 50 | 4 Jahre | |
| Robert D. Mashal | M | - | - | |
| Matthew Fust | M | 59 | 10 Jahre | |
| Michael Narachi | M | 64 | 9 Jahre | |
| Karen S. Wright | F | 69 | 3 Jahre | |
| Erik Harris | M | 54 | 9 Jahre | |
| Corazon Sanders | M | 67 | 3 Jahre | |
| Dennis Selkoe | M | 80 | 11 Jahre | |
| Dennis Huang | M | 59 | 11 Jahre | |
| Chet Leach | M | - |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| Jessica Lifton | F | - |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | - |
| Luiz Belardinelli | M | - |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 8 Jahre |
| Mark Bach | M | 67 | 3 Jahre | |
| Sara Brownstein | F | 38 |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | - |
| Michael Dybbs | M | 49 |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | - |
| Sherry Pudloski | F | - | 1 Jahre | |
| David Caouette | M | - | 3 Jahre | |
| Natasha Hernday | F | 52 | 13 Jahre | |
| Cui Ping Gu | M | 44 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | - |
| Chris Boshoff | M | - | 1 Jahre | |
| Andrew ElBardissi | M | 42 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| Perry Nisen | M | 68 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 6 Jahre |
| Johan Rutger Christenson | M | 65 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Clay Siegall | M | 63 | 25 Jahre | |
| Peter Staple | M | 72 | 12 Jahre | |
| James Healy | M | 58 | 16 Jahre | |
| Jonathan Leff | M | 55 | 16 Jahre | |
| David Gryska | M | 68 | 18 Jahre | |
| Srini Akkaraju Akkaraju | M | 56 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 17 Jahre |
| Felix Baker | M | 55 | 20 Jahre | |
| Sunil Agarwal | M | 54 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 3 Jahre |
| Eran Nadav | M | 55 | 4 Jahre | |
| Grace E. Colón | M | 57 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 10 Jahre |
| Darren Cline | M | 59 | 10 Jahre | |
| Sara Cotter | F | 43 |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | - |
| Ashley C. Gould | F | 49 | - | |
| Donald Santel | M | 62 | 8 Jahre | |
| Terrence Kearney | M | 69 |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | 6 Jahre |
| Chris Rallis | M | 70 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | 8 Jahre |
| Jonathan Silverstein | M | 57 | 7 Jahre | |
| John C. Hodgman | M | 69 | - | |
| Barbara Duncan | F | 59 | 7 Jahre | |
| Vaughn Himes | M | 63 | 14 Jahre | |
| Bill Aliski | M | 75 | 11 Jahre | |
| Philip Donenberg | M | 63 | 2 Jahre | |
| Lota Zoth | F | 64 | 7 Jahre | |
| Mark Vignola | M | 47 | 4 Jahre | |
| Keith Gottesdiener | M | 70 | 7 Jahre | |
| Klaus Veitinger | M | 62 | 4 Jahre | |
| Phyllis Gardner | M | 73 | 11 Jahre | |
| Bong Koh | M | - | - | |
| Paul Manning | M | 68 | 4 Jahre | |
| Gary W. Cleary | M | 81 | 19 Jahre | |
| Carole Nüchterlein | F | 63 | 3 Jahre | |
| Christopher Rivera | M | 63 | 9 Jahre | |
| Jennifer James | F | - |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 4 Jahre |
| Shalini Sharp | F | 49 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 11 Jahre |
| Bhaskar Chaudhuri | M | 69 | 8 Jahre | |
| Paul Goddard | M | 74 | 4 Jahre | |
| David Greenwood | M | 72 | 8 Jahre | |
| Michael B. Johannesen | M | - | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 87 | 87,00% |
| Irland | 14 | 14,00% |
| China | 7 | 7,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel Welch
- Persönliches Netzwerk
